Related Experiment Video
Updated: May 17, 2026
09:03
Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation
Published on: November 17, 2014
MicroRNAs as biomarkers in solid organ transplantation.
Summary
MicroRNAs (miRNAs) show promise as biomarkers for solid organ transplantation. These molecules can help diagnose graft injury and monitor treatment, improving long-term transplant outcomes.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Solid organ transplantation has seen limited improvement in long-term outcomes despite advances in short-term results.
- A significant need exists for biomarkers to assess donor quality, detect graft injury early, and monitor treatment response.
Purpose of the Study:
- To review recent findings on microRNAs (miRNAs) as biomarkers in organ transplantation.
- To highlight the potential of miRNAs in assessing organ quality, ischemia-reperfusion injury, rejection, tolerance, and chronic allograft dysfunction.
Main Methods:
- Literature review of recently published reports on miRNA biomarkers in transplantation.
- Analysis of studies identifying specific miRNAs associated with various transplant outcomes.
- Evaluation of mechanistic roles and clinical applications of circulating miRNAs.
Main Results:
- Circulating miRNAs are detectable in biological fluids and can differentiate between healthy and diseased individuals.
- MiRNA expression patterns are linked to physiological conditions and diseases, including transplant complications.
- Recent research has identified specific miRNAs as potential biomarkers for organ quality and various forms of allograft injury and dysfunction.
Conclusions:
- MicroRNAs hold significant potential as noninvasive biomarkers for monitoring allograft injury and function in solid organ transplantation.
- Further research is needed to address methodological limitations and fully realize the clinical utility of miRNA biomarkers in transplantation.
